MHRA approves ingredients for general sale
This article was originally published in The Tan Sheet
Executive Summary
The U.K. Medicines and Healthcare products Regulatory Agency approves salicylic acid 12 percent with lactic acid 4 percent for general sale (similar to OTC status) for the topical treatment of warts, verrucas, corns and calluses in consumers older than 2 years. It also approves the general sale of dimeticone 4 percent for head lice in patients at least 6 months old, the U.K. regulatory authority announced July 22